<SEC-DOCUMENT>0001144204-15-059071.txt : 20151013 <SEC-HEADER>0001144204-15-059071.hdr.sgml : 20151012 <ACCEPTANCE-DATETIME>20151013090928 ACCESSION NUMBER: 0001144204-15-059071 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151013 DATE AS OF CHANGE: 20151013 EFFECTIVENESS DATE: 20151013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NQ HCIF GP, Ltd. CENTRAL INDEX KEY: 0001598203 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16645 FILM NUMBER: 151154779 BUSINESS ADDRESS: STREET 1: 4208 SIX FORKS ROAD STREET 2: SUITE 920 CITY: RALEIGH STATE: NC ZIP: 27609 BUSINESS PHONE: (919) 459-8620 MAIL ADDRESS: STREET 1: 4208 SIX FORKS ROAD STREET 2: SUITE 920 CITY: RALEIGH STATE: NC ZIP: 27609 </SEC-HEADER> <DOCUMENT> <TYPE>13F-HR <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> <XML> <?xml version="1.0" encoding="UTF-8"?> <edgarSubmission xsi:schemaLocation="http://www.sec.gov/edgar/thirteenffiler eis_13F_Filer.xsd" xmlns="http://www.sec.gov/edgar/thirteenffiler" xmlns:ns1="http://www.sec.gov/edgar/common" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> <headerData> <submissionType>13F-HR</submissionType> <filerInfo> <liveTestFlag>LIVE</liveTestFlag> <flags> <confirmingCopyFlag>false</confirmingCopyFlag> <returnCopyFlag>false</returnCopyFlag> <overrideInternetFlag>false</overrideInternetFlag> </flags> <filer> <credentials> <cik>0001598203</cik> <ccc>XXXXXXXX</ccc> </credentials> </filer> <periodOfReport>09-30-2015</periodOfReport> </filerInfo> </headerData> <formData> <coverPage> <reportCalendarOrQuarter>09-30-2015</reportCalendarOrQuarter> <isAmendment>false</isAmendment> <filingManager> <name>NQ HCIF GP, Ltd.</name> <address> <ns1:street1>4208 Six Forks Road</ns1:street1> <ns1:street2>Suite 920</ns1:street2> <ns1:city>Raleigh</ns1:city> <ns1:stateOrCountry>NC</ns1:stateOrCountry> <ns1:zipCode>27609</ns1:zipCode> </address> </filingManager> <reportType>13F HOLDINGS REPORT</reportType> <form13FFileNumber>028-16645</form13FFileNumber> <provideInfoForInstruction5>Y</provideInfoForInstruction5> <additionalInformation>The securities listed in the table below are held by NovaQuest Pharma Opportunities Fund III, L.P. ("NovaQuest"). NQ HCIF General Partner, L.P., the general partner of NovaQuest ("NovaQuest GP"), may be deemed to exercise investment discretion with respect to the securities directly owned by NovaQuest, and NQ HCIF GP, Ltd., the general partner of NovaQuest GP ("NovaQuest GP Ltd."), may be deemed to direct NovaQuest GP as to such investment discretion. The filing of this report or any related report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g) or 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the rules thereunder, or for any other purpose, that NovaQuest GP, NovaQuest GP Ltd. or any other person exercises investment discretion with respect to the securities listed herein or is a member of, or is otherwise affiliated with, such a group with respect to such securities. Reference is made, where relevant, to reports filed under Sections 13(d), 13(g) and 16(a) of the Exchange Act for additional information with respect to such beneficial ownership and/or pecuniary interest of NovaQuest GP and NovaQuest GP Ltd. The filing of this report or any related report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g) or 16(a) of the Exchange Act and the rules thereunder, or for any other purpose, that NovaQuest GP and NovaQuest GP Ltd. or any other person is the beneficial owner of any securities.</additionalInformation> </coverPage> <signatureBlock> <name>John L. Bradley, Jr.</name> <title>Director</title> <phone>919-459-8622</phone> <signature>/s/ John L. Bradley, Jr.</signature> <city>Raleigh</city> <stateOrCountry>NC</stateOrCountry> <signatureDate>10-12-2015</signatureDate> </signatureBlock> <summaryPage> <otherIncludedManagersCount>2</otherIncludedManagersCount> <tableEntryTotal>1</tableEntryTotal> <tableValueTotal>92156</tableValueTotal> <otherManagers2Info> <otherManager2> <sequenceNumber>2</sequenceNumber> <otherManager> <cik>0001506260</cik> <form13FFileNumber>028-16648</form13FFileNumber> <name>NovaQuest Pharma Opportunities Fund III, L.P.</name> </otherManager> </otherManager2> <otherManager2> <sequenceNumber>3</sequenceNumber> <otherManager> <cik>0001598327</cik> <form13FFileNumber>028-16646</form13FFileNumber> <name>NQ HCIF General Partner, L.P.</name> </otherManager> </otherManager2> </otherManagers2Info> </summaryPage> </formData> </edgarSubmission> </XML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>INFORMATION TABLE <SEQUENCE>2 <FILENAME>infotable.xml <TEXT> <XML> <?xml version="1.0" ?> <informationTable xsi:schemaLocation="http://www.sec.gov/edgar/document/thirteenf/informationtable eis_13FDocument.xsd" xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:n1="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> <infoTable> <nameOfIssuer>REVANCE THERAPEUTICS INC</nameOfIssuer> <titleOfClass>COM</titleOfClass> <cusip>761330109</cusip> <value>92156</value> <shrsOrPrnAmt> <sshPrnamt>3096650</sshPrnamt> <sshPrnamtType>SH</sshPrnamtType> </shrsOrPrnAmt> <investmentDiscretion>DFND</investmentDiscretion> <otherManager>2,3</otherManager> <votingAuthority> <Sole>3096650</Sole> <Shared>0</Shared> <None>0</None> </votingAuthority> </infoTable> </informationTable> </XML> </TEXT> </DOCUMENT> </SEC-DOCUMENT>